Compare MKSI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MKSI | SNN |
|---|---|---|
| Founded | 1961 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 14.3B |
| IPO Year | 1997 | N/A |
| Metric | MKSI | SNN |
|---|---|---|
| Price | $270.11 | $33.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $255.62 | $36.25 |
| AVG Volume (30 Days) | ★ 961.4K | 661.2K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | 0.37% | ★ 2.25% |
| EPS Growth | ★ 55.52 | N/A |
| EPS | ★ 4.37 | N/A |
| Revenue | ★ $3,931,000,000.00 | N/A |
| Revenue This Year | $15.87 | $8.61 |
| Revenue Next Year | $10.78 | $5.60 |
| P/E Ratio | ★ $61.54 | $64.97 |
| Revenue Growth | ★ 9.62 | N/A |
| 52 Week Low | $58.85 | $25.45 |
| 52 Week High | $272.71 | $38.79 |
| Indicator | MKSI | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 67.22 | 57.91 |
| Support Level | $208.96 | $32.03 |
| Resistance Level | N/A | $37.23 |
| Average True Range (ATR) | 11.83 | 0.54 |
| MACD | 4.78 | 0.29 |
| Stochastic Oscillator | 98.30 | 99.45 |
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.